Polychaete systematics: Past and present

In this paper, we first demonstrate the historical background for the current unsatisfactory state of systematics of the polychaetes. We then briefly discuss our knowledge of internal and external structures. A review of the polychaete families makes up the third section; 81 families are treated in detail. Five families have been recently synonymized with others, and six families are too poorly known to be sufficiently characterized. Fossil polychaetes are briefly mentioned, with specific attention to problems associated with incorporating them in recent systematics.
The traditional separation in 'errant' and 'sedentary' polychaetes has increasingly become recognized as being unsatisfactory; however, the current trend towards grouping the polychaetes in many orders without specifying the relationships among the orders, is no more satisfactory. The lack of consistent morphological information is a major source of uncertainty. Intensive morphological studies should remove terminological ambiguities and alleviate some of the problems.     

p120-catenin: Past and present

p120-catenin was first described in 1989 as a Src substrate whose phosphorylation correlated with transformation. It was identified by cDNA cloning in 1992, and shown to interact with cadherins in 1994. Though enigmatic for some time, p120 has emerged as a master regulator of cadherin stability, and an important modulator of RhoGTPase activities. With the discovery of p120 family members and evidence for fundamental roles in cell biology and cancer, the field has expanded dramatically in recent years. As an introduction to this collection of reviews on p120 and its relatives, the editors have requested a personal commentary and historical perspective on the discovery of p120. The anecdotal parts have no particular purpose, but are mostly unpublished and perhaps of interest to some.     

Glycoproteomics: Past, present and future

This invited paper reviews the study of protein glycosylation, commonly known as glycoproteomics, beginning with the origins of the subject area in the early 1970s shortly after mass spectrometry was first applied to protein sequencing. We go on to describe current analytical approaches to glycoproteomic analyses, with exemplar projects presented in the form of the complex story of human glycodelin and the characterisation of blood group H eptitopes on the O-glycans of gp273 from Unio elongatulus. Finally, we present an update on the latest progress in the field of automated and semi-automated interpretation and annotation of these data in the form of GlycoWorkBench, a powerful informatics tool that provides valuable assistance in unravelling the complexities of glycoproteomic studies.     

Serum ferritin: Past,present and future

Background

Serum ferritin was discovered in the 1930s, and was developed as a clinical test in the 1970s. Many diseases are associated with iron overload or iron deficiency. Serum ferritin is widely used in diagnosing and monitoring these diseases.

Scope of review

In this chapter, we discuss the role of serum ferritin in physiological and pathological processes and its use as a clinical tool.

Major conclusions

Although many aspects of the fundamental biology of serum ferritin remain surprisingly unclear, a growing number of roles have been attributed to extracellular ferritin, including newly described roles in iron delivery, angiogenesis, inflammation, immunity, signaling and cancer.

General significance

Serum ferritin remains a clinically useful tool. Further studies on the biology of this protein may provide new biological insights.     

Biomphalaria alexandrina in Egypt: Past, present and future

The African species of Biomphalaria appeared as a result of the relatively recent west-to-east trans-Atlantic dispersal of the Biomphalaria glabrata-like taxon. In Egypt, Biomphalaria alexandrina is the intermediate host for Schistosoma mansoni. Biomphalaria alexandrina originated in the area between Alexandria and Rosetta and has historically been confined to the Nile Delta. Schistosoma mansoni reached Egypt via infected slaves and baboons from the Land of Punt through migrations that occurred as early as the Vth Dynasty. The suggestion of the presence of Schistosoma mansoni infection in Lower Egypt during Pharaonic times is discussed despite the fact that that there is no evidence of such infection in Egyptian mummies. It is only recently that Biomphalaria alexandrina colonized the Egyptian Nile from the Delta to Lake Nasser. This change was likely due to the construction of huge water projects, the development of new water resources essential for land reclamation projects and the movement of refugees from the Suez Canal zone to the Delta and vice versa. The situation with respect to Biomphalaria in Egypt has become complicated in recent years by the detection of Biomphalaria glabrata and a hybrid between both species; however, follow-up studies have demonstrated the disappearance of such species within Egypt. The National Schistosoma Control Program has made great strides with respect to the eradication of schistosoma; however, there has unfortunately been a reemergence of Schistosoma mansoni resistant to praziquantel. There are numerous factors that may influence the prevalence of snails in Egypt, including the construction of water projects, the increase in reclaimed areas, global climate change and pollution. Thus, continued field studies in addition to the cooperation of several scientists are needed to obtain an accurate representation of the status of this species. In addition, the determination of the genome sequence for Biomphalaria alexandrina and the use of modern technology will allow for the study of the host–parasite relationship at a molecular level.     

Past and present distribution of the genus Capra in Greece

The Alpine ibex Capra ibex and the wild goat Capra aegagrus are the only caprids known to have existed in the Balkan Peninsula. The agrimi is a feral primitive form of the domestic goat Capra hircus but may constitute an island subspecies of C. aegagrus endemic to Crete, Greece. Here, the distribution of C. ibex and C. aegagrus in this southernmost Balkan country was reviewed for the period from Middle Pleistocene until today through a scientific and historical document search. Such knowledge should provide directions to future conservation plans for these species and aid in tracing the origins of agrimi. Fossil locations indicate that both species lived in this country at elevations of similar altitude (≥10–?≤?2,497 m a.s.l.). C. ibex colonised Greece naturally, perhaps, not earlier than 126,000 years ago. It was spread over most of the mainland (36–41° N and 20–24° E) where from it disappeared after 5600 BC due to hunting. C. aegagrus constituted an exotic in Europe. Man introduced it to insular and mainland Greece (between 35–40° N and 19–26° E) from around 8600 and 7000 BC, respectively. It went extinct on the mainland probably before 6000 BC. Only C. ibex should, therefore, be restored to its former Balkan ranges. This review provides further support for the wild origin hypothesis for agrimi.     

European protected areas: Past,present and future

The Habitats Directive celebrates its 20th anniversary in 2012. The influence of the Directive now extends across 27 Member States, compared to just 12 when it was first adopted in May 1992. The sites now cover more than 17% of the land surface of the Member States. However, in spite of their deep roots in human history, reviewed here, and their long-time justification on the basis of intrinsic value, protected areas must face the economic challenges of the modern era. There is a need for policy that can guide decision-making in relation to their continued designation, protection and management, including the ecosystem services that they deliver and taking into account the needs of the local communities who live and work in and around them. Growing pressures include their potential exploitation for economic and commercial benefit and the continued threats from competition over land use and climate change.     

Amperometric enzyme biosensors: Past,present and future

Three groups of the amperometric biosensors such as unmediated, mediated and based on direct transfer of electrons have been thoroughly described, and their advantages and disadvantages were shown. The amperometric biosensors are mostly utilized in commercial devices since they are studied to a greater extent and have some advantages. The modern commercial systems based on amperometric biosensors and its applications have been presented. The major field of employing biosensors is medical diagnostics where numerous commercial devices are currently functioning.     

Therapeutic myocardial angiogenesis: Past, present and future

One of the main goals in the treatment of myocardial ischemia is the development of effective therapy for angiogenesis and neovascularization. The first evidence demonstrating alleviation of myocardial ischemia and increased number of collateral blood vessels was reported in the early 90s following intra-coronary administration of basic fibroblast growth factor protein in canine. This study established the ground for extensive investigations to demonstrate the use of other angiogenic growth factor proteins, genes administered directly or incorporated in viruses, and more recently, endothelial progenitor stem cells (embryonic and adults). The positive results observed in animals failed, in most cases, to repeat themselves in clinical trials in human patients. Therefore, additional experiments are warranted to allow full understanding of the mechanism underlying new blood vessel formation before further clinical studies are undertaken. This review will explore the milestones of angiogenic investigations and their clinical application. (Mol Cell Biochem 264: 75–83, 2004)     

Laboratory diagnosis of melioidosis: Past,present and future

Melioidosis is an emerging, potentially fatal disease caused by Burkholderia pseudomallei, which requires prolonged antibiotic treatment to prevent disease relapse. However, difficulties in laboratory diagnosis of melioidosis may delay treatment and affect disease outcomes. Isolation of B. pseudomallei from clinical specimens has been improved with the use of selective media. However, even with positive cultures, identification of B. pseudomallei can be difficult in clinical microbiology laboratories, especially in non-endemic areas where clinical suspicion is low. Commercial identification systems may fail to distinguish between B. pseudomallei and closely related species such as Burkholderia thailandensis. Genotypic identification of suspected isolates can be achieved by sequencing of gene targets such as groEL which offer higher discriminative power than 16S rRNA. Specific PCR-based identification of B. pseudomallei has also been developed using B. pseudomallei-specific gene targets such as Type III secretion system and Tat-domain protein. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry, a revolutionary technique for pathogen identification, has been shown to be potentially useful for rapid identification of B. pseudomallei, although existing databases require optimization by adding reference spectra for B. pseudomallei. Despite these advances in bacterial identification, diagnostic problems encountered in culture-negative cases remain largely unresolved. Although various serological tests have been developed, they are generally unstandardized “in house” assays and have low sensitivities and specificities. Although specific PCR assays have been applied to direct clinical and environmental specimens, the sensitivities for diagnosis remain to be evaluated. Metabolomics is an uprising tool for studying infectious diseases and may offer a novel approach for exploring potential diagnostic biomarkers. The metabolomics profiles of B. pseudomallei culture supernatants can be potentially distinguished from those of related bacterial species including B. thailandensis. Further studies using bacterial cultures and direct patient samples are required to evaluate the potential of metabolomics for improving diagnosis of melioidosis.     

Past and present concepts in flow cytometry: a European perspective

The development of flow cytometric instrumentation, methods and research concepts in Europe has been a continuous driving force for the general scientific advancement in this area over the years. This review addresses early European concepts of continuing interest with regard to instrumentation, data analysis, clinical and eperimental DNA analysis, cell function and microbiology at their worldwide first appearence while flow cytometric immunology and immunophenotyping will be covered separately. Flow cytometry represents an efficient approach to the enormous complexity of molecular cell architecture and cell function by the analysis of apparent molecular cell phenotypes in heterogeneous cell samples. The present merger of flow and image cytometry into the method independent cytomics discipline increases the potential of cell analysis very significantly. It opens the way for predictive medicine as well as for predictive cytopathology and predictive cytology in everyday clinical and medical practice. Current progress is driven by joint advances in molecular fluorescence technologies and instrument development. This complements the analysis of genome sequence information in an efficient way.     

Behavior research in zoos: Past,present, and future

This paper reviews the historical emphases in zoo behavioral research and the contribution of these studies to animal management and to advancement in the behavioral sciences. Some examples are provided from research conducted at the National Zoological Park and elsewhere. The potential for doing behavior studies of excellence in zoos and aquariums has become more complicated in recent years by 1) changes in the aims and objectives of modern zoological parks, especially the increasing emphasis on conservation, 2) changes in focus in the science of animal behavior itself, and 3) the tendency of trained behaviorists to assume positions as curators and directors without time for research. These issues represent challenges to be overcome so that zoos can continue to be important sites for the study of animal behavior and contribute to the science of animal management and conservation, as well as the advancement of theory in biology. © 1992 Wiley-Liss, Inc.